Cadre Holdings, Inc. Files 2023 Annual Report on Form 10-K
Ticker: CDRE · Form: 10-K · Filed: Mar 12, 2024 · CIK: 1860543
| Field | Detail |
|---|---|
| Company | Cadre Holdings, INC. (CDRE) |
| Form Type | 10-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.0001, $21.80, $0, $870 million, $245 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, Annual Report, Cadre Holdings, Financials, SEC Filing
TL;DR
<b>Cadre Holdings, Inc. has filed its 2023 10-K report detailing its financial performance and business operations for the fiscal year ending December 31, 2023.</b>
AI Summary
Cadre Holdings, Inc. (CDRE) filed a Annual Report (10-K) with the SEC on March 12, 2024. Cadre Holdings, Inc. filed its 2023 Form 10-K on March 12, 2024. The filing covers the fiscal year ending December 31, 2023. The company's SIC code is 3842 for Orthopedic, Prosthetic & Surgical Appliances & Supplies. Cadre Holdings, Inc. is incorporated in Delaware. The company's principal business address is 13386 International Pkwy, Jacksonville, FL 32218.
Why It Matters
For investors and stakeholders tracking Cadre Holdings, Inc., this filing contains several important signals. This 10-K filing provides a comprehensive overview of Cadre Holdings' financial health, operational performance, and strategic direction for the past fiscal year, crucial for investors and stakeholders to assess the company's current standing and future prospects. As a public company, Cadre Holdings is required to disclose detailed financial information, including revenue, expenses, assets, liabilities, and equity, which are essential for market analysis and investment decisions.
Risk Assessment
Risk Level: low — Cadre Holdings, Inc. shows low risk based on this filing. The filing is a standard 10-K annual report, which is routine for publicly traded companies and does not contain immediate red flags.
Analyst Insight
Review the detailed financial statements and risk factors within the 10-K to understand Cadre Holdings' performance and potential challenges.
Key Numbers
- 20231231 — Conformed Period of Report (Fiscal Year End)
- 20240312 — Filed as of Date (Filing Date)
- 0001860543 — Central Index Key (Company Identifier)
- 383873146 — IRS Number (Tax Identification)
- 001-40698 — SEC File Number (Regulatory Filing Number)
Key Players & Entities
- Cadre Holdings, Inc. (company) — Filer
- 3842 (dollar_amount) — Standard Industrial Classification
- DE (company) — State of Incorporation
- 13386 International Pkwy (company) — Business Address Street 1
- JACKSONVILLE (company) — Business Address City
- FL (company) — Business Address State
- 32218 (company) — Business Address Zip
- (904) 741-5400 (company) — Business Phone
FAQ
When did Cadre Holdings, Inc. file this 10-K?
Cadre Holdings, Inc. filed this Annual Report (10-K) with the SEC on March 12, 2024.
What is a 10-K filing?
A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by Cadre Holdings, Inc. (CDRE).
Where can I read the original 10-K filing from Cadre Holdings, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Cadre Holdings, Inc..
What are the key takeaways from Cadre Holdings, Inc.'s 10-K?
Cadre Holdings, Inc. filed this 10-K on March 12, 2024. Key takeaways: Cadre Holdings, Inc. filed its 2023 Form 10-K on March 12, 2024.. The filing covers the fiscal year ending December 31, 2023.. The company's SIC code is 3842 for Orthopedic, Prosthetic & Surgical Appliances & Supplies..
Is Cadre Holdings, Inc. a risky investment based on this filing?
Based on this 10-K, Cadre Holdings, Inc. presents a relatively low-risk profile. The filing is a standard 10-K annual report, which is routine for publicly traded companies and does not contain immediate red flags.
What should investors do after reading Cadre Holdings, Inc.'s 10-K?
Review the detailed financial statements and risk factors within the 10-K to understand Cadre Holdings' performance and potential challenges. The overall sentiment from this filing is neutral.
How does Cadre Holdings, Inc. compare to its industry peers?
Cadre Holdings, Inc. operates within the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, as indicated by its SIC code 3842.
Are there regulatory concerns for Cadre Holdings, Inc.?
The company is subject to the reporting requirements of the Securities Exchange Act of 1934, as evidenced by its filing of a Form 10-K.
Industry Context
Cadre Holdings, Inc. operates within the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, as indicated by its SIC code 3842.
Regulatory Implications
The company is subject to the reporting requirements of the Securities Exchange Act of 1934, as evidenced by its filing of a Form 10-K.
What Investors Should Do
- Analyze the company's financial statements for the fiscal year ended December 31, 2023.
- Review the business description and risk factors outlined in the 10-K.
- Note the company's incorporation in Delaware and its principal business address.
Key Dates
- 2024-03-12: 10-K Filing — Annual report submission date
- 2023-12-31: Fiscal Year End — Period covered by the 10-K
- 2021-11-03: IPO — Initial Public Offering date
Year-Over-Year Comparison
This is the initial 10-K filing for the fiscal year 2023, following previous filings for prior periods.
Filing Stats: 4,392 words · 18 min read · ~15 pages · Grade level 14.9 · Accepted 2024-03-12 16:32:02
Key Financial Figures
- $0.0001 — ) On Which Registered Common Stock, $0.0001 Par Value per Share CDRE New York S
- $21.80 — 0,482,938 based on the closing price of $21.80 as reported by the New York Stock Excha
- $0 — 7,436 shares of common stock, par value $0.0001, outstanding Documents Incorporat
- $870 million — actical soft armor) to be approximately $870 million. We also estimate explosive ordnance di
- $245 million — an addressable market of approximately $245 million over the seven-to-ten year life cycle o
- $380 million — litary is estimated to be approximately $380 million. The international law enforcement mar
- $528 billion — dated cleanup from the DoE related to a $528 billion liability that exists from legacy defen
- $3 billion — r nuclear safety products to be between $3 billion and $6 billion based on the need for ou
- $6 billion — y products to be between $3 billion and $6 billion based on the need for our products by t
Filing Documents
- cdre-20231231x10k.htm (10-K) — 2687KB
- cdre-20231231xex19d1.htm (EX-19.1) — 54KB
- cdre-20231231xex21d1.htm (EX-21.1) — 29KB
- cdre-20231231xex23d1.htm (EX-23.1) — 6KB
- cdre-20231231xex31d1.htm (EX-31.1) — 11KB
- cdre-20231231xex31d2.htm (EX-31.2) — 11KB
- cdre-20231231xex32d1.htm (EX-32.1) — 8KB
- cdre-20231231xex32d2.htm (EX-32.2) — 7KB
- cdre-20231231xex97d1.htm (EX-97.1) — 51KB
- cdre-20231231x10k001.jpg (GRAPHIC) — 21KB
- cdre-20231231x10k002.jpg (GRAPHIC) — 30KB
- cdre-20231231x10k003.jpg (GRAPHIC) — 14KB
- cdre-20231231x10k004.jpg (GRAPHIC) — 38KB
- cdre-20231231xex19d1001.jpg (GRAPHIC) — 7KB
- 0001558370-24-002995.txt ( ) — 13141KB
- cdre-20231231.xsd (EX-101.SCH) — 72KB
- cdre-20231231_cal.xml (EX-101.CAL) — 86KB
- cdre-20231231_def.xml (EX-101.DEF) — 328KB
- cdre-20231231_lab.xml (EX-101.LAB) — 731KB
- cdre-20231231_pre.xml (EX-101.PRE) — 614KB
- cdre-20231231x10k_htm.xml (XML) — 2475KB
Business
Item 1. Business 5
Risk Factors
Item 1A. Risk Factors 13
Unresolved Staff Comments
Item 1B. Unresolved Staff Comments 32
Cybersecurity
Item 1C. Cybersecurity 32
Properties
Item 2. Properties 33
Legal Proceedings
Item 3. Legal Proceedings 33
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 33 PART II
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 34
[Reserved]
Item 6. [Reserved] 35
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 36
Quantitative and Qualitative Disclosures About Market Risk
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 45
Financial Statements and Supplementary Data
Item 8. Financial Statements and Supplementary Data 47
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 80
Controls and Procedures
Item 9A. Controls and Procedures 80
Other Information
Item 9B. Other Information 81 PART III
Directors, Executive Officers and Corporate Governance
Item 10. Directors, Executive Officers and Corporate Governance 81
Executive Compensation
Item 11. Executive Compensation 82
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 82
Certain Relationships and Related Transactions, and Director Independence
Item 13. Certain Relationships and Related Transactions, and Director Independence 82
Principal Accounting Fees and Services
Item 14. Principal Accounting Fees and Services 82 PART IV
Exhibits and Financial Statement Schedules
Item 15. Exhibits and Financial Statement Schedules 82 2 Table of Contents CAUTIONARY STATEMENT This Annual Report on Form 10-K (this "Report") contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Except where the context otherwise requires or where otherwise indicated, the terms the "Company", "Cadre", "we," "us," and "our," refer to the consolidated business of Cadre Holdings, Inc. and its consolidated subsidiaries. All statements in this Report, other than statements of historical fact, are forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, hopes, beliefs, intentions, and strategies regarding future events and are based on currently available information as to the outcome and timing of future events. In some cases, you can identify forward-looking statements because they contain words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "could," "plan," "predict," "potential," "seem," "seek," "future," "outlook," or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. The Company cautions you that these forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company, incident to its business. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. These forward-looking statements are based on information available as of the date of this Report (or, in the case of forward-looking statements incorporated herein by reference, if any, as of the date of the applicable filed document), and any accompanyi
BUSINESS
BUSINESS Business Overview For over 60 years, we have been a global leader in the manufacturing and distribution of safety equipment for professionals. Our equipment provides critical protection which allows its users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Through our dedication to superior quality, we establish a direct covenant with end users that our products will perform and keep them safe when they are most needed. We sell a wide range of products including body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products through both direct and indirect channels. In addition, through our owned distribution, we serve as a one-stop shop for first responders providing equipment we manufacture as well as third-party products including uniforms, optics, boots, firearms, and ammunition. The majority of our diversified product offering is governed by rigorous safety standards and regulations. Demand for our products is driven by technological advancement as well as recurring modernization and replacement cycles for the equipment to maintain its efficiency, effective performance, and regulatory compliance. Domestically, we are a top provider of safety holsters and soft body armor for first responders, as well as a top provider of nuclear safety solutions. Globally, we are a leading provider of explosive ordnance disposal technician equipment. We believe we have achieved these positions through our high-quality standards, innovation and a direct connection to the end users. We service the ever-changing needs of our end users by investing in research and development for new product innovation and technical advancements that continually raise the standards for safety equipment in the markets we serve. Our target end user base includes state, local, and international law enforcement, fire and rescue, explosive ordnance disposal technicians, commercial nuclear power plants, emergen